Artivion Inc AORT

NYS: AORT | ISIN: US2289031005 1/07/2025

30,75 USD (-1,13%)

(-1,13%) 1/07/2025

Grafiek Artivion Inc

Grafiek Artivion Inc

1 dag1d -1,13%
1 week1w 0,49%
1 maand1m 7,11%
3 maanden3m 22,75%
6 maanden6m 9,51%
1 jaar1j 19,88%
5 jaar5j 56,73%

Artivion Inc in het nieuws

Toon enkel gratis nieuws

14 mei 2025 · Artivion Announces Agreements to Exchange $95 Million in Principal Amount of its 4.250% Convertible Notes Due 2025 for Common Stock · Persbericht

5 mei 2025 · Artivion Reports First Quarter 2025 Financial Results · Persbericht

5 mei 2025 · Artivion Announces Presentation of New Clinical Data from NEXUS TRIOMPHE IDE Trial at the 105th American Association for Thoracic Surgery (AATS) Annual Meeting · Persbericht

21 april 2025 · Artivion Announces Release Date and Teleconference Call Details for First Quarter 2025 Financial Results · Persbericht

4 maart 2025 · Artivion to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference · Persbericht

8 augustus 2024 · Artivion Reports Second Quarter 2024 Financial Results · Persbericht

5 augustus 2024 · Artivion to Participate in Upcoming Investor Conferences · Persbericht

25 juli 2024 · Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2024 Financial Results · Persbericht

1 juli 2024 · Artivion Amends Agreements with Endospan · Persbericht

6 mei 2024 · Artivion Reports First Quarter 2024 Financial Results · Persbericht

Profiel Artivion Inc

Gezondheidstechnologie

Medische Specialiteiten

Productie van medische instrumenten

Website: www.cryolife.com

Hoofdzetel: Kennesaw, Georgia Verenigde Staten

CEO: James Mackin

Werknemers: 399

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe